v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Income Statement [Abstract]      
Net sales and revenue $ 650,487 $ 642,491 $ 833,384
Cost of sales (includes $86.4 million, $99.2 million and $117.0 million with related parties for the years ended January 31, 2026, 2025 and 2024, respectively) 556,781 551,014 735,166
Gross profit 93,706 91,477 98,218
Selling, general and administrative expenses (32,616) (27,148) (29,379)
Equity in income of unconsolidated affiliates 12,485 9,385 13,921
Interest and other income, net 14,997 19,158 15,724
Income before income taxes 88,572 92,872 98,484
Benefit (provision) for income taxes 6,502 (21,386) (22,560)
Net income 95,074 71,486 75,924
Net income attributable to noncontrolling interests (12,123) (13,319) (14,989)
Net income attributable to REX common shareholders $ 82,951 $ 58,167 $ 60,935
Weighted average shares outstanding – basic (in Shares) 33,208 35,272 34,964
Basic net income per share attributable to REX common shareholders (in Dollars per share) $ 2.5 $ 1.65 $ 1.74
Weighted average shares outstanding – diluted (in Shares) 33,208 35,272 35,151
Diluted net income per share attributable to REX common shareholders (in Dollars per share) $ 2.5 $ 1.65 $ 1.73